Using MRI to examine tendon structure and metabolism
Official title: MRI of Tendon Structure and Metabolism
Funded at Emory University · NIH-10835122 · Data updated 2026-11-12
This study is looking at a new way to use MRI to see how healthy your tendons are and how they’re working, which could help improve treatments for painful tendon problems.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | May 1, 2023 |
| Project end | April 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $200,383 |
| NIH project number | 5R21AR080869-02 |
| Project ID | NIH-10835122 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals experiencing pain or dysfunction related to tendon injuries, particularly in the achilles or calcanean tendons.
✕Less likely to help
Patients with acute tendon injuries or those who do not have tendon-related pain may not receive benefit from this research.
What this research studies
This research aims to develop a non-invasive MRI technique to assess damage in the extracellular matrix (ECM) and cellular energy metabolism in human tendons. Tendinopathies, which are painful conditions affecting joints, often result from chronic overuse and can be difficult to treat. By utilizing advanced MRI technology, the study seeks to provide detailed insights into tendon health and function, potentially leading to better treatment strategies. Patients with tendon issues may benefit from this innovative imaging approach that could enhance understanding of their condition.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and treatment options for patients suffering from tendon injuries.
How similar studies have gone: Other research has shown promise in using advanced MRI techniques for assessing tendon health, indicating that this approach may yield valuable insights.
Where this research is happening
-
Emory University
Atlanta, United States Active
Researchers
- Principal investigator: Reiter, David a — Emory University
- Study coordinator: Reiter, David a
Related research
Other NIH-funded projects on the same topics.
-
Administrative and Engagement Core for Breast Cancer Breakthrough in Kenya
A national effort in Kenya to speed up how we screen for breast cancer and connect women to treatment, using teamwork across institutions.
-
Collaborative research program to advance patient care
A multi-project research effort at Emory University aims to push forward medical knowledge that could help people with illnesses in the future.
-
Project-003: A multi-partner research program at Emory University
A multi-faceted NIH grant at Emory University aims to advance understanding in a focused area over several years to benefit patients with diseases or conditions connected to the research.
-
Project-002: advancing patient care through coordinated research at Emory
A multi-project NIH grant at Emory aims to translate findings into better care for people with a health condition by coordinating research efforts across teams.
-
Project-006: A Multidisciplinary Emory Initiative to Advance Medical Understanding
A multi-project NIH grant at Emory University aims to push forward medical knowledge in areas that could eventually help patients.
-
Project-005: A multi-component research effort at Emory University
A multi-part NIH grant from Emory University aims to advance understanding in a specific health area over several years with potential patient benefits in the future.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.